• Home
  • News
  • An Interview with MiraxBioPharma’s CEO

An Interview with MiraxBioPharma’s CEO

Brand transformation — first-hand account

A major interview with Vadim Drukh, General Director of MiraxBioPharma JSC, was published on one of the leading industry platforms – pharmvestnik.ru. The dialogue touched upon the Company’s rebranding, strategic directions, and pharmaceutical market evolution. The conversation was both engaging and candid — we invite you to read it.

Еще новости

«МираксБиоФарма» представляет новый логотип и фирменный стиль

"MiraxBioPharma" unveils new logo and brand identity

Contact us

Select a service*

Pharmacovigilance

MiraxBioPharma is committed to ensuring the quality and safety of its products and pays special attention to collecting and analyzing information about adverse reactions and complaints associated with the use of our products.

If you become aware of any adverse reactions to the medicinal product Cezarox® Epi or of a lack of therapeutic effect, please report it via email at: adversareaction@drugsafety.ru or by phone: +7 (800) 777-86-04.

If you become aware of any adverse reactions to other MiraxBioPharma medicinal products or of a lack of therapeutic effect, please report it via email at: GVP@mbpharma.ru, by phone: +7 (495) 183-38-41 or by filling out the electronic form below

Adverse reaction reporting form
Specify gender*
Suspected medicinal product information
Reporter information

Preferred method of contact*
We use cookies

By using this website, you consent to the collection and processing of your personal data, including through third-party services, and the use of cookies and web analytics tools, under the terms outlined in the Personal Data Processing Policy.